Corline Biomedical AB (STO:CLBIO)
Sweden · Delayed Price · Currency is SEK 18.20
-0.10 (-0.55%)
May 22, 2026, 5:11 PM CET
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 475.62 million as of May 22, 2026. Its market cap has increased by 89.47% in one year.
Market Cap
475.62M
Enterprise Value
442.72M
Revenue
10.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.20
Market Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 475.62M, an increase of 385.50%. That is a compound annual growth rate of 15.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 475.62M | 34.95% |
| Dec 30, 2025 | 352.45M | 86.79% |
| Dec 30, 2024 | 188.69M | -41.07% |
| Dec 29, 2023 | 320.21M | 61.61% |
| Dec 30, 2022 | 198.15M | -36.85% |
| Dec 30, 2021 | 313.77M | 25.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SynAct Pharma AB | 784.02M |
| Infant Bacterial Therapeutics AB | 749.01M |
| Cantargia AB | 731.42M |
| FluoGuide | 678.50M |
| Oncopeptides AB | 646.29M |
| Intervacc AB | 432.83M |
| Ascelia Pharma AB | 385.25M |
| Mendus AB | 349.07M |